The global sales of pharmaceutical glass packaging are estimated to be worth USD 20,815.8 million in 2024 and are anticipated to reach a value of USD 30,420.9 million by 2034. Sales are projected to rise at a CAGR of 3.9% over the forecast period between 2024 and 2034. The revenue generated by pharmaceutical glass packaging in 2023 was USD 20,120.2 million. The industry is anticipated to exhibit a Y-o-Y growth of 3.5% in 2024.
While various end users exist in the market, the share of pharmaceutical companies is around 52.9% of the total market share in the year 2024. A large number of packaging products, specifically glass, are most importantly used by pharmaceutical companies to store, transport and protect a variety of drug products in order to ensure their quality and safety.
Global Pharmaceutical Glass Packaging Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 20,120.2 million |
| Estimated Size, 2024 | USD 20,815.8 million |
| Projected Size, 2034 | USD 30,420.9 million |
| Value-based CAGR (2024 to 2034) | 3.9% |
Ampoules & vials are anticipated to reach 27.2% of the market share in 2034 and generate incremental opportunity worth USD 2,116.0 million by the end of the assessment years. Plastic ampoules & vials are predominantly used in the pharmaceutical industry because of their efficacy, reliability, and integrity of medicines from production to administration.
Prevention of contamination and sterility is essential to maintain the quality of the medications. Ampoules & vials are safe and they are sold with stoppers and caps that maintain the medicine's integrity from production to administration. Ampoules & vials are not sensitive to environmental factors which is an excellent factor for protecting medications from contamination.
The Type I glass is expected to hold more than 75% of the value share within the global market by the end of 2024 with a 4.1% growth rate. Type I glass; commonly referred to as borosilicate is made from high-grade resistant material to chemicals, water and temperature hence is widely preferred in pharmaceutical glass packaging.
The glass is very inert hence very little chance of the products that it holds from inside coming in contact with the surface of the container. In addition to that, Type I glass can also endure extreme temperatures in addition to thermal shocks hence ideal for use in sterilization. It has a very high transparency hence the contents can be easily viewed for inspection purposes, which helps in further preserving the quality and safety of the products.
The pharmaceutical glass packaging industry is set to experience moderate growth during the forecast period. It is projected to create an incremental opportunity of USD 9,132.2 million and is predicted to rise 1.4 times the current market value through 2034.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The below table presents the expected CAGR for the global pharmaceutical glass packaging market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 3.7%, followed by a slightly lower growth rate of 4.1% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 3.7% (2023 to 2033) |
| H2 | 4.1% (2023 to 2033) |
| H1 | 3.8% (2024 to 2034) |
| H2 | 4.0% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 3.8% in the first half and remain relatively moderate at 4.0% in the second half. In the first half (H1) the market witnessed an increase of 10 BPS while in the second half (H2), the market witnessed a decrease of 10 BPS.
Rising Preference of Glass Syringes and Vials in Vaccine Packaging
Packaging sustainability is a rising area of dialogue and coordination between states, industry, universities, and regulatory bodies. To improve the natural, social and economic resilience of packaging, product advances and content production would be crucial. Vials made of glass significantly dominate the entire vaccine packaging market, as they are non-reactive with contents and can deliver multi-doses in a single pack. However, from a sustainability benefit point of view, prefilled syringes are now taking over the vials.
Being unit-dose, and ready-to-administer, prefilled syringes are "safety-by-design" because of their intrinsic ease of usage, removal of many error-prone steps in the preparing and delivery of the vaccine, decreased risk of cross-contamination of the syringe, and guarantee of the proper dose for each injection.
In comparison, printed peel-off labels on prefilled vaccine syringes make it easy to record batch numbers and update the immunization record of the patient at a faster rate than vials. The rising application of glass syringes and vials in pharmaceutical packaging especially for vaccine boost the market sales.
Elevated Standards towards Healthcare
Healthcare and safety has emerged as one of the prominent growing sectors which is expected to increase the demand for glass packaging. Inclination of consumers towards the safety and originality of the products leading manufacturers and brands to adopt glass packaging solutions for their products. The glass packaging is highly safer than other type of packaging.
There is no danger concerning toxic materials or chemicals penetration into the merchandise, thus health risk to the consumer is the least. There is an observed shift towards healthier living among consumers and therefore they are consciously searching for eco-friendly options in their everyday buying behaviors.
The rising demand for generic medicines including over-the-counter medicines, capsules, and syrups globally has generated lucrative sales of the market. The improving health concerns among people acted as a great opportunity for the pharmaceutical industry to influence the development of pharmaceutical glass packaging.
The inertness and unreactive properties of glass have led to its increased adoption in pharmaceutical products as these products focus on the conditions of the packaged products and consumer safety. Glass packaging helps in ensuring the integrity of the contents which is essential for sensitive pharmaceutical products.
Increased focus on the visual appeal and product transparency which helps to gain the consumer's attention to the products. Consumers are increasingly focusing on healthcare, and hygiene, and seeking solutions that signify safety, quality and sustainability which led to the increased demand for glass packaging.
Challenges of Glass Delamination May Impact Pharmaceutical Glass Packaging Market
A major concern in the pharmaceutical market is delamination in glass containers, which threatens the drug's stability and may put the patients at risk. This occurs when layers begin to separate, thus glass flakes tend to get into the medicine. This glass contamination can ruin the drug’s content rendering it ineffective and dangerous to the users.
Besides, the presence of delaminated glass can result in an increase in quality control and compliance costs which hinders the expansion of the pharmaceutical glass packaging market. To curb these risks, strategies advanced production techniques and stringent testing regimes need to be adopted.
As the regulations become more stringent and the consumers are worried about their safety, the problem of delamination will have to be solved in order to maintain the reliability and security of the pharmaceutical glass packaging, which is likely to restrict the growth of the market as a whole.
Principal Consultant
The global pharmaceutical glass packaging industry recorded a CAGR of 3.1% during the historical period between 2019 and 2023. The growth of the pharmaceutical glass packaging industry was positive as it reached a value of USD 20.1 million in 2023 from USD 17.7 million in 2019.
Due to the exponential number of patients during the pandemic, the requirement for medicines and relevant medical equipment increased. This drove the pharmaceutical glass packaging market growth during the historical period. The growing pharmaceutical industry has mainly generated the demand for glass packaging because of its inertness and safety.
The ageing population, the rising prevalence of chronic diseases, and rising accidental cases created more demand for medicines leading to increasing medicinal packaging. Many medicines and syrups are regulated to be packed in glass-based packaging to maintain the integrity of the products which is highly fueling demand for glass packaging solutions in the pharmaceutical industry.
Glass packaging materials fulfil efficient storage and handling requirements of patient samples. This has increased the demand for glass bottles, vials, and syringes. Glass, being low reactive than plastic, enhances the storage properties of medicinal packaging. This maintains the quality of the collected sample, providing accurate diagnosis results. Hence, this driver will likely enlarge the pharmaceutical glass packaging market size.
The growing biotechnology field will require safe transportation and better handling of medicines. The major companies present in the pharmaceutical glass packaging market are likely to devise appropriate new products for this purpose. Hence, this will represent a primary factor affecting the growth of the glass pharmaceutical packaging market.
The growing concern regarding sustainability surged the demand for suitable packaging solutions. Sustainable packaging in eco-friendly and recyclable material is rooting itself in the market boosting the pharmaceutical glass packaging market.
Tier 1 companies in the global pharmaceutical glass packaging industry include Owens-Illinois, Inc., Corning Incorporated, Gerresheimer AG, Schott AG, Nipro Corporation, Stölzle Glass Group and West Pharmaceutical Services, Inc with market revenue above USD 250 million.
These manufacturers are market leaders in pharmaceutical glass packaging within global industry having extensive production capacity, different product offerings, and extensive manufacturing expertise. These companies are capturing around 15% to 20% of global market share in the pharmaceutical glass packaging industry.
Tier 2 of the global pharmaceutical glass packaging industry incorporates companies like Ardagh Group S.A., Vetropack Holding Ltd., Sisecam Group, Verallia, Bormioli Pharma Srl, Stevanato Group (Ompi), SGD Pharma, Kavalierglass GMBH, DWK Life Sciences GmbH, Beatson Clark Ltd., Agrado S.A., Hindusthan National Glass & Industries Limited with revenue of USD 10 to 250 million.
They have limited presence, and well-maintained knowledge but may not have expertise and advanced manufacturing technology. These manufacture have mostly limited regional presence having knowledge and demand of regional market dynamics.
Tier 3 category in the global pharmaceutical glass packaging market includes the small-scale players of the region with revenue below USD 10 million. These companies fulfil the local market demand and are recognized as an unorganized market. They have a country level presence, limited manufacturing facilities, and expertise in local market needs. They are well established in local market and fulfill the local market demands.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis of the pharmaceutical glass packaging market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, South Asia & Pacific, East Asia, Western Europe, Eastern Europe, and others, is provided. North America have contributed 1/4th of market share in 2024. South Asia Pacific has anticipated to record 5.8% of growth rate during forecast period.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| USA | 2.8% |
| Germany | 1.8% |
| UK | 2.9% |
| Canada | 3.5% |
| India | 6.5% |
| China | 4.4% |
| Japan | 5.1% |
| Brazil | 3.4% |
Aged people are more prone to chronic diseases which is an effective driving factor for the vaccine packaging market. In Japan, 1 out of 10 people are above 80 years or older and the country is rated to have the world’s oldest population.
The World Economic Forum stated that almost 1/3rd of Japan's population is over 65 years which accounts for 36.23 million people contributing to the older population. This is the major factor influencing the demand for pharmaceutical glass packaging in the country. Japan is anticipated to be at 5.1% CAGR and capture 27% of market share in East Asia by 2034 end.
The USA leads in North America with more than 67% of the market share in 2024 and is anticipated to expand to reach USD 4,659.2 million sales by the end of the assessment period. According to the Centre for Disease Control and Prevention (CDC), around 1,603,844 cancer cases were reported in the United States out of which 602,347 died due to cancer in the year 2020.
403 new cancer cases are being reported for every 100,000 people out of which 104 died because of cancer. These fatalities stem from the absence of medical care and therapeutics to cure and preserve the life of the patients. This is likely to aim at introducing more cancer treatment drugs through clinical trials in the USA which considerably enhances the need of pharmaceutical glass such as vials, syringes, etc. in the region for the prevention and management of these diseases.
The section contains information about the leading segments in the industry. In terms of product, bottles are projected to reach 27.9% of market share through 2034. By end user, pharmaceutical companies are anticipated to capture a market share of 53.6% over the forecast period.
| Product | Bottles |
|---|---|
| CAGR (%) | 2.4% |
Glass bottles are the most predominantly used in pharmaceutical glass packaging pushed by their excellent durability. Glass bottles offer moisture barriers and other contaminants to preserve the freshness, flavor, and quality of packaged products.
Biopharmaceutical and vaccine applications majorly prefer glass bottles for packaging due to their stability and non-reactiveness. High demand for eco-friendly and cost-effective packaging solutions is also estimated to fuel growth. Glass bottles are estimated to reach USD 8.4 million in sales revenue by the end of 2034
| End Use | Pharmaceutical Companies |
|---|---|
| CAGR (%) | 4.0% |
Pharmaceutical industries are leading the global pharmaceutical glass packaging industry driven by the need to maintain safety, product integrity, and stringent regulations. Glass offers inert and impermeable packaging barriers to the product contained to ensure no external factors compromise the medicine’s purity and stability.
This is a crucial characteristic apart from withstanding sterilization methods and providing accurate dosage forms. This makes the glass an ultimate in the preferred materials for pharmaceutical companies. The thirst for invention and the need to safeguard patients influences the pharmaceutical sector to source the most dependable and quality glass packaging.
Several prominent players in the pharmaceutical glass packaging market are significantly investing in innovation, research, and development to discover new applications and enhance their offerings. Manufactures prioritize safety, product quality, and customer satisfaction to expand their customer base.
Key manufacturers of pharmaceutical glass packaging are focusing on developing recycled material packaging and developing packaging solutions to meet sustainability demand. They are adopting merger & acquisition strategy to expand their resources and are developing new products to meet customer needs.
Recent Industry Developments in Pharmaceutical Glass Packaging Market
Pharmaceutical glass packaging industry is divided into Type I, Type II and Type III.
Pharmaceutical glass packaging industry is segregated into bottles, syringes, ampoules & vials and cartridges.
The industry is classified by oral medications, injectable medications, topical medications and ophthalmic medications.
The industry is classified by end use as pharmaceutical companies, biopharmaceutical companies, contract manufacturing organizations (CMO) and research laboratories.
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, and Middle East and Africa (MEA), have been covered in the report.
The global pharmaceutical glass packaging industry is projected to witness CAGR of 3.9% between 2024 and 2034.
The global pharmaceutical glass packaging industry stood at USD 20,120.2 million in 2023.
The global pharmaceutical glass packaging industry is anticipated to reach USD 30,420.9 million by 2034 end.
South Asia and Pacific is set to record the highest CAGR of 5.8% in the assessment period.
The key players operating in the global pharmaceutical glass packaging industry include includes Owens-Illinois, Inc., Corning Incorporated, Gerresheimer AG, Schott AG, Nipro Corporation, Stölzle Glass Group and West Pharmaceutical Services, Inc.
Packaging
February 2024
REP-GB-1446
200 pages
Explore Packaging Insights
View Reports
Pharmaceutical Glass Packaging Market
